Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CRIZANLIZUMAB-TMCA Cause Ill-defined disorder? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Ill-defined disorder have been filed in association with CRIZANLIZUMAB-TMCA. This represents 0.6% of all adverse event reports for CRIZANLIZUMAB-TMCA.

7
Reports of Ill-defined disorder with CRIZANLIZUMAB-TMCA
0.6%
of all CRIZANLIZUMAB-TMCA reports
1
Deaths
5
Hospitalizations

How Dangerous Is Ill-defined disorder From CRIZANLIZUMAB-TMCA?

Of the 7 reports, 1 (14.3%) resulted in death, 5 (71.4%) required hospitalization.

Is Ill-defined disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CRIZANLIZUMAB-TMCA. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does CRIZANLIZUMAB-TMCA Cause?

Pain (313) Sickle cell anaemia with crisis (263) Back pain (125) Infusion related reaction (110) Arthralgia (81) Pain in extremity (75) Drug ineffective (74) Chest pain (63) Pyrexia (62) Nausea (57)

What Other Drugs Cause Ill-defined disorder?

ACETAMINOPHEN\OXYCODONE (9,780) ACETAMINOPHEN\HYDROCODONE (6,159) TOCILIZUMAB (4,411) RITUXIMAB (4,220) ETANERCEPT (4,202) METHOTREXATE (4,063) ABATACEPT (3,630) LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (3,600) LEFLUNOMIDE (3,570) CERTOLIZUMAB PEGOL (3,273)

Which CRIZANLIZUMAB-TMCA Alternatives Have Lower Ill-defined disorder Risk?

CRIZANLIZUMAB-TMCA vs CRIZOTINIB CRIZANLIZUMAB-TMCA vs CROFELEMER CRIZANLIZUMAB-TMCA vs CROMOLYN CRIZANLIZUMAB-TMCA vs CROTALIDAE POLYVALENT IMMUNE FAB CRIZANLIZUMAB-TMCA vs CUBICIN

Related Pages

CRIZANLIZUMAB-TMCA Full Profile All Ill-defined disorder Reports All Drugs Causing Ill-defined disorder CRIZANLIZUMAB-TMCA Demographics